Study ID

Progression Free Survival

Median Survival

1‐year survival

2‐year survival

5‐year survival

Response Rate

Van Hazel 2004 (n=21)

Chemo + SIRT: 11.5 months vs. Chemo: 4.6 months.

HR: 0.23 (CI 0.08‐0.68)

Chemo + SIRT: 29.4 months vs. Chemo: 11.8 months.

HR: 0.22 (CI 0.07‐0.74)

Chemo + SIRT: 82% vs. Chemo: 50%

Chemo + SIRT: 64% vs. Chemo: 20%

Chemo + SIRT: 0% vs. Chemo: 0%

Chemo + SIRT: 73% vs. Chemo: 0%

Van Hazel 2004. No extra‐hepatic disease (n=15)

Chemo + SIRT: 19.1 months vs. Chemo: 4.9 months.

HR: 0.23 (CI 0.06‐0.96)

Chemo + SIRT: 31.9 months vs. Chemo:13.8 months.

HR: 0.24 (CI 0.06‐0.99)

Chemo + SIRT: 78% vs. Chemo: 67%

Chemo + SIRT: 67% vs. Chemo: 33%

Chemo + SIRT: 0% vs. Chemo: 0%

Chemo + SIRT: 78% vs. Chemo: 0%

Study ID

Progression Free Survival

Median Survival

1‐year survival

2‐year survival

5‐year survival

Response Rate

Gray 2001 (n=63)

Chemo + SIRT: 7.3 months vs. Chemo: 5.9 months.

HR: 0.72 (CI 0.43‐1.21)

Chemo + SIRT: 17.6 months vs. Chemo: 15.6 months.

HR: 0.62 (CI 0.37‐1.05)

Chemo + SIRT: 71% vs. Chemo: 61%

Chemo + SIRT: 37% vs. Chemo:29%

Chemo + SIRT: 6% vs. Chemo: 0%

Chemo + SIRT: 37% vs. Chemo: 14%

Gray 2001.

No extra‐hepatic disease (n=22)

Chemo + SIRT: 2.7 months vs. Chemo: 4.3 months.

HR: 0.72 (0.27‐1.90)

Chemo + SIRT: 14.2 months vs. Chemo: 15.6 months.

HR: 0.54 (CI 0.20‐1.44)

Chemo + SIRT: 63% vs. Chemo: 64%

Chemo + SIRT: 50% vs. Chemo: 21%

Chemo + SIRT: 13% vs. Chemo: 0%

Chemo + SIRT: 25% vs. Chemo: 14%